Patents
Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
05/2008
05/15/2008WO2008058278A2 POLYMORPHS OF N2-(1, 1' - BIPHENYL - 4 - YLCARBONYL) - N1- [2- (4 - FLUOROPHENYL) -1, 1 - DIMETHYLETHYL]- L - α -GLUTAMINE
05/15/2008WO2008055669A1 Salt of aliskiren with orotic acid
05/15/2008US20080114062 N-(2-hydroxy-1-methyl-ethyl)-3-iodobenzamide; for the treatment of a muscular disorder, a gastrointestinal disorder, or for controlling spasticity or tremors; modulates cannabinoid receptors
05/15/2008US20080113989 For example, N-(1-Carbamoyl-1-oxo-3-phenylpropan-2-yl)-2-(E-2-(4-(1-pyrrolidinylmethyl)phenyl)ethen-1-yl)benzamide; calcium channel blockers; cardiovascular disorders; antiarthritic agents; inhibitors of enzymes, especially cysteine proteases such as calpain and cathepsins
05/15/2008US20080113976 asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis; Azetidine-1-carboxylic acid {2-[({2-hydroxy-1-[(isopropyl-methyl-amino)-methyl]-pentylcarbamoyl}-methyl)-carbamoyl]-4-trifluoromethyl-phenyl}-amide
05/15/2008US20080113939 N-geranylgalacturonamide; anticarcinogenic, antitumor agent
05/15/2008US20080112946 Catalytically active recombinant memapsin and methods of use thereof
05/15/2008CA2665073A1 Salt of aliskiren with orotic acid
05/14/2008EP1919509A2 Highly cross-linked reagents for modifying biopharmaceuticals, production and use thereof
05/14/2008EP1264821B1 Novel crystal of stilbene derivative and process for producing the same
05/14/2008CN101180267A Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof
05/14/2008CN101180266A Alpha ketoamide compounds as cysteine protease inhibitors
05/14/2008CN100387606C Method for the production of cyclic phosphonic acid anhydrides
05/13/2008US7371896 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
05/13/2008US7371872 (1R,4S,5S,6S)-4-(2'S-4'-methylthio-2'-aminobutanonyl)amino-2,2-dioxo-2 lambda 6-thia-bicyclo[3.1.0]hexane-4,6-dicarboxylic acid; nervous system, psychological, and psychiatric disorders
05/13/2008US7371867 Non-racemic trifluoroleucine, and methods of making and using
05/08/2008WO2008053360A2 Albumin binding molecules and uses thereof
05/08/2008CA2669726A1 Albumin binding molecules and uses thereof
05/07/2008EP1918272A1 Pharmaceutically active compounds and methods of use
05/06/2008US7368101 Process for the preparation of iopamidol and the new intermediates therein
05/06/2008CA2125636C Process for preparing an .alpha.-amino acid amide, useful for peptidic synthesis
05/02/2008CA2631024A1 Anthranilic acid derivatives useful in treating infection with hepatitis c virus
04/2008
04/30/2008EP1916236A1 Amide derivative, pesticide containing such compound and use thereof
04/30/2008EP1915328A1 Continuous crystallisation process of iodinated phenyl derivatives
04/30/2008EP1506168B1 Gelling agents
04/30/2008CN101171230A Heterocyclic-substituted alkanamides useful as renin inhibitors
04/30/2008CN100384889C Polymerization of olefins
04/29/2008US7365225 Aryl dicarboxamides
04/29/2008US7365087 Oxazole derivatives of tetracyclines
04/29/2008CA2336474C C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
04/29/2008CA2254833C Pharmaceutical for treatment of neurological and neuropsychiatric disorders
04/24/2008US20080097109 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
04/24/2008US20080096869 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
04/23/2008EP1913976A1 N-alpha-(menthane carbonyl) amino acid amides and their use as physiological coolants
04/23/2008EP1912933A1 Insecticidal 3-acylaminobenzanilides
04/23/2008EP1912679A2 Amine-containing lipids and uses thereof
04/23/2008EP1007033B1 Lymphocyte function antigen-1 antagonists
04/23/2008CN101164543A Acyl pseudopeptides bearing a functionalised auxiliary spacer
04/22/2008USRE40259 side effects reduction; compounds active on the central nervous system; chronic and neuropathic pain, anti-epileptic, anti-Parkinson, neuroprotective, antidepressant, antispastic and hypnotic agents; 2-[4-(3-fluorobenzyloxy)benzylamino]-2-methylpropanamide
04/22/2008US7361787 Prophylaxis of respiratory disorders and therapy, also metod of synthesis and composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent
04/22/2008US7361688 Substituted aminoalcohols useful in treatment of Alzheimer's disease
04/22/2008US7361674 7, 8 and 9-substituted tetracycline compounds
04/17/2008WO2008045507A2 Substituted tetracycline compounds for treatment of bacillus anthracis infections
04/17/2008WO2008044443A1 Gadolinium compound and contrast medium for mri
04/17/2008WO2008043911A2 Dendritic chelated compounds, methods for making the same and pharmaceutical compositions containing the same
04/17/2008US20080090916 2-Amino-4-[(1S,2R)-2-(2,5-dimethoxyphenyl)-2-hydroxy-1-methyl-ethylcarbamoyl]butyric acid, aka gamma-L-glutamyl-1R,2S-methoxamine; prodrug of 1R,2S-methoxamine that is converted within the kidney tubules into its active form; transdermal administration; coupling methoxamine with glutamic acid alcohol
04/17/2008US20080090789 Tigecycline crystalline forms and processes for preparation thereof
04/16/2008EP1911751A1 Amide derivative and pesticide containing such compound
04/16/2008EP1910279A2 Non-nucleoside anti-hepacivirus agents and uses thereof
04/16/2008EP1910274A1 Phenyl compounds
04/16/2008EP1910273A2 10-substituted tetracyclines and methods of use thereof
04/16/2008EP1909572A2 Potassium channel inhibitors
04/16/2008EP1426356B1 Intermediate compounds for the preparation of mirtazapine and the production methods thereof
04/16/2008EP1414787B1 New derivatives of substituted anilines with herbicidal activity
04/16/2008CN100381418C Gelling agents
04/15/2008US7358386 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
04/15/2008US7358276 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
04/15/2008US7358264 Statine derivatives for the treatment of Alzheimer's disease
04/15/2008CA2154424C 1-phenyl-3-dimethylaminopropane compounds having a pharmaceutical effect
04/10/2008US20080085894 Alpha-(n-sulfonamido)acetamide derivatives as beta-amyloid inhibitors
04/10/2008CA2848238A1 Lipid containing formulations
04/09/2008EP1908466A1 Substituted propanamide derivative and pharmaceutical composition containing the same
04/09/2008EP1907356A2 Process for the preparation of sulfonamide derivatives
04/09/2008CN101160282A Acetylene derivatives
04/09/2008CN100379719C Substituted aminomethyl-phenyl-cyclohexane derivatives
04/09/2008CN100379718C N alpha-Boc-N beta-Cbz-L-2,3 diaminopropionic acid derivative synthesis method
04/08/2008US7354943 Statine derivatives for the treatment of Alzheimer's disease
04/03/2008DE102004011720B4 Radiohalogenierte Benzamidderivate und deren Verwendung in der Tumordiagnostik und Tumortherapie Radio Halogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy
04/02/2008EP1904435A2 Benzamide derivatives and uses related thereto
04/02/2008CN100378047C Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them
04/01/2008US7351719 Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
03/2008
03/27/2008US20080076824 Compounds That Inhibit Replication Of Human Immunodeficiency Virus
03/27/2008US20080076769 Norvaline Derivative and Method for Preparation Thereof
03/27/2008US20080073272 Method of separating isotopes
03/27/2008DE102006042147A1 Hydrochloride von 3-Amino-2-hydroxycarbonsäureamiden Hydrochloride of 3-amino-2-hydroxycarboxamides
03/26/2008EP1903028A1 Conjugates of glutamate and NMDA receptor channel blockers without excito-toxic effects
03/26/2008EP1902014A2 Glutamate aggrecanase inhibitors
03/26/2008EP1641754B1 Process and intermediates for the preparation of (1r, 2s, 5s)-3- azabicyclo[ 3, 1, 0]hexane-2-carboxamide, n- [3-amino -1-(cyclobutylmethyl)-2, 3-dioxopropyl] ]-3- [ (2s)- 2-[[[1, 1-dimethylethyl ]amino]carbonyla mino ]-3, 3-dimethyl-1-oxobutyl] -6, 6-dimethyl
03/26/2008CN101148418A Alpine yarrow herb ketoacid derivatives and applications thereof
03/25/2008USRE40183 7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
03/25/2008CA2484638C Polyene polyketides and methods of production
03/25/2008CA2268709C Hiv protease inhibitors
03/20/2008WO2008032156A1 Diaryl ether derivatives and uses thereof
03/20/2008WO2008031509A1 ISOSERINE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS
03/20/2008WO2008019090A3 Agonists of the sphingosine-1-phosphate receptor
03/20/2008WO2007127292A3 Tigeycline crystalline forms and processes for preparation thereof
03/20/2008CA2663544A1 Isoserine derivatives for use as coagulation factor ixa inhibitors
03/19/2008EP1900759A2 Polymer production
03/19/2008EP1900364A2 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
03/19/2008EP1898899A1 Inhibitors of fibroblast activation protein alpha
03/19/2008EP1898884A2 Manufacturing process for tigecycline
03/19/2008EP1819663B1 Omega-phenyloctanamides
03/18/2008US7345174 Selectively inducing terminal differentiation of neoplastic cells; antiproliferative agents; antineoplastic agents; antitumor agents; melanomes; acute leukemia, multiple myeloma; carcinomas; neuroblastoma; N-t-butoxycarbonyl- omega -methyl - alpha -aminosuberateanilide
03/13/2008WO2008030112A1 Processes of preparing asymmetric dinitrobenzamide mustard compounds, intermediate compounds useful therein and products obtained therefrom
03/13/2008WO2008029912A1 Compound having benzamide skeleton and cyclooxygenase (cox-1)-selective inhibitory activity
03/13/2008WO2008029267A2 Hydrochlorides of 3-amino-2-hydroxy carboxamides
03/13/2008US20080064873 Oxidizing an amino alcohol (obtained by ring opening the epoxy, aziding, reducing and reacting it with a carboxylic acid); stereoselectivity; protease inhibitors: antiallergens; anticarcinogenic and hypotensive agents
03/13/2008US20080064748 Substituted enaminones, their derivatives and uses thereof
03/13/2008US20080064720 Very Late Antigen-4 dependent inflammatory disease; asthma, allergic rhinitis, sinusitis, conjunctivitis, food allergy, inflammatory skin disorders, autoimmune disorders, or atherosclerosis, inflammatory skin disorder; methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-hydroxy-2-propenoate
03/13/2008US20080064667 5,8-bis(dimethylamino)-2-(2,2-diphenylvinyl)-9,11a,12-trihydroxy-11,13-dioxo-6,6a,7,7a,8,11,11a,13-octahydrotetraceno[2,1-d][1,3]oxazole-10-carboxamide; effective against minocycline- and tetracycline-resistant bacteria
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 162